Rodrigo Arriagada

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study
    Alberto J Montero
    Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 104:229-35. 2005
  2. ncbi Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathologic factors and the risk of death in each 5-year period
    Rodrigo Arriagada
    Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
    Cancer 106:743-50. 2006
  3. ncbi Number of positive axillary lymph nodes and post-mastectomy radiotherapy effect in breast cancer patients
    Rodrigo Arriagada
    Radiother Oncol 84:102-3; discussion 103-4; author reply 104-5. 2007
  4. ncbi Predicting distant dissemination in patients with early breast cancer
    Rodrigo Arriagada
    Karolinska Institutet, Stockholm, Sweden
    Acta Oncol 47:1113-21. 2008
  5. ncbi OECI Workshop on late side-effects of cancer treatments
    R Arriagada
    Karolinska Institutet and Hospital, Department of Radiation Oncology, Radiumhemmet, SE 171 76, Stockholm, Sweden
    Eur J Cancer 45:354-9. 2009
  6. ncbi Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer
    Rodrigo Arriagada
    Institut Gustave Roussy, rue Camille Desmoulins, Villejuif 94800, France
    J Clin Oncol 28:35-42. 2010
  7. ncbi Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up
    Céline Bourgier
    Department of Radiation Oncology, Breast Unit, Institut Gustave Roussy, Villejuif, France
    Int J Radiat Oncol Biol Phys 82:690-5. 2012
  8. ncbi Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a r
    Cécile Le Péchoux
    Radiotherapy Department, Institut Gustave Roussy, Villejuif, France
    Lancet Oncol 10:467-74. 2009
  9. ncbi Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1146 patients with early breast cancer
    Rodrigo Arriagada
    Institut Gustave Roussy, Villejuif, France
    Acta Oncol 44:458-66. 2005
  10. ncbi Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer
    Anne Auperin
    Unit of Biostatistics and Epidemiology, Institut Gustave Roussy, 94805 Villejuif Cedex, France
    J Clin Oncol 28:2181-90. 2010

Detail Information

Publications29

  1. ncbi The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study
    Alberto J Montero
    Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 104:229-35. 2005
    ..However, despite such improvements, survival rates remained low, and innovative therapeutic approaches are, therefore, needed to improve clinical outcomes...
  2. ncbi Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathologic factors and the risk of death in each 5-year period
    Rodrigo Arriagada
    Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
    Cancer 106:743-50. 2006
    ..The objective of this study was to assess the effect of prognostic factors on the risk of death in patients with breast carcinoma over a long follow-up...
  3. ncbi Number of positive axillary lymph nodes and post-mastectomy radiotherapy effect in breast cancer patients
    Rodrigo Arriagada
    Radiother Oncol 84:102-3; discussion 103-4; author reply 104-5. 2007
  4. ncbi Predicting distant dissemination in patients with early breast cancer
    Rodrigo Arriagada
    Karolinska Institutet, Stockholm, Sweden
    Acta Oncol 47:1113-21. 2008
    ....
  5. ncbi OECI Workshop on late side-effects of cancer treatments
    R Arriagada
    Karolinska Institutet and Hospital, Department of Radiation Oncology, Radiumhemmet, SE 171 76, Stockholm, Sweden
    Eur J Cancer 45:354-9. 2009
    ..One of the main Workshop objectives was to generate recommendations on how to improve knowledge and, consequently, long-term care for cancer survivors...
  6. ncbi Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer
    Rodrigo Arriagada
    Institut Gustave Roussy, rue Camille Desmoulins, Villejuif 94800, France
    J Clin Oncol 28:35-42. 2010
    ....
  7. ncbi Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up
    Céline Bourgier
    Department of Radiation Oncology, Breast Unit, Institut Gustave Roussy, Villejuif, France
    Int J Radiat Oncol Biol Phys 82:690-5. 2012
    ....
  8. ncbi Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a r
    Cécile Le Péchoux
    Radiotherapy Department, Institut Gustave Roussy, Villejuif, France
    Lancet Oncol 10:467-74. 2009
    ..A meta-analysis suggested that the incidence of brain metastases might be reduced with higher PCI doses. This randomised clinical trial compared the effect of standard versus higher PCI doses on the incidence of brain metastases...
  9. ncbi Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1146 patients with early breast cancer
    Rodrigo Arriagada
    Institut Gustave Roussy, Villejuif, France
    Acta Oncol 44:458-66. 2005
    ..Adjuvant anthracycline-based chemotherapy yielded a significant benefit for DFS by lowering the risk of distant metastases. After up to 10 years of follow-up, deferring radiotherapy after chemotherapy did not compromise local control...
  10. ncbi Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer
    Anne Auperin
    Unit of Biostatistics and Epidemiology, Institut Gustave Roussy, 94805 Villejuif Cedex, France
    J Clin Oncol 28:2181-90. 2010
    ..The NSCLC Collaborative Group performed a meta-analysis of randomized trials directly comparing concomitant versus sequential radiochemotherapy...
  11. ncbi CXCR4 expression in early breast cancer and risk of distant recurrence
    Fabrice Andre
    Breast Medical Oncology Unit, Department of Radiation Therapy, Department of Pathology and Translational Research Unit UPRES EA03535, Institut Gustave Roussy, University of Paris XI, Villejuif, France
    Oncologist 14:1182-8. 2009
    ..e., liver, lung, brain, and bone)...
  12. ncbi Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer?
    Thierry Le Chevalier
    Institut Gustave Roussy, Faculte de Medecine Paris Sud, 94800 Villejuif, France
    Lancet Oncol 6:182-4. 2005
    ..In this debate, Thierry Le Chevalier and colleagues and Giorgio Scagliotti present opposing arguments for whether this approach should be considered standard...
  13. ncbi Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients
    Monique G Le
    Institut Gustave Roussy, Villejuif, France
    Clin Breast Cancer 6:439-45. 2005
    ..We studied whether dermal lymphatic emboli (DLE) add independent prognostic information to the clinical definition of inflammatory breast cancer (IBC)...
  14. ncbi Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients
    Berrin Pehlivan
    Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
    Acta Oncol 48:440-5. 2009
    ..We aimed to evaluate whether a daily PI is worthwhile and we derived the Planning Target Volume (PTV) margins from the estimation of systematic and random errors...
  15. ncbi Prophylactic cranial irradiation in small cell lung cancer
    Cécile Le Péchoux
    Department of Radiotherapy, Institut Gustave Roussy, Villejuif 94805, France
    Hematol Oncol Clin North Am 18:355-72. 2004
  16. ncbi Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease
    Céline Bourgier
    Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
    Radiother Oncol 96:199-203. 2010
    ..Local treatments seem to improve metastasis progression-free survival (MPFS) and overall survival (OS) when added to systemic therapies in stage IV breast cancer...
  17. ncbi Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma
    Monique G Le
    INSERM Unit 521, Institut Gustave Roussy, Villejuif, France
    Cancer 94:2813-20. 2002
    ..The authors analyzed the outcome of patients with early-stage breast carcinoma after an isolated local recurrence, taking into account initial tumor characteristics and the type of initial treatment and local salvage treatment...
  18. ncbi Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer
    Yungan Tao
    Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
    Acta Oncol 47:442-50. 2008
    ..A long-term follow-up will be needed to evaluate potential late treatment complications related to the use of IMRT and the low or moderate irradiation dose level obtained in the pelvis and in the whole body...
  19. ncbi Long-term mortality in a cohort study of 6,800 French breast cancer patients treated between 1954 and 1983
    Houda Boukheris
    National Institute of Health and Medical Research, Villejuif, France
    Acta Oncol 47:1122-32. 2008
    ..To investigate the impact of initial tumour characteristics and loco-regional radiotherapy on long-term survival following breast cancer diagnosis...
  20. ncbi Increased risk of recurrence after hormone replacement therapy in breast cancer survivors
    Lars Holmberg
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
    J Natl Cancer Inst 100:475-82. 2008
    ..We present results after extended follow-up...
  21. ncbi Choroid metastases: clinical features and treatments in 123 patients
    Rodrigo Arriagada
    Ophthalmology Unit, Institut Gustave-Roussy, Villejuif Cedex, France
    Cancer 98:1232-8. 2003
    ..However, because treatments were not prescribed randomly, the results of the current study should be interpreted with caution...
  22. ncbi Resected non-small cell lung cancer: need for adjuvant lymph node treatment? From hope to reality
    Rodrigo Arriagada
    Instituto de Radiomedicina IRAM, Américo Vespucio Norte 1314, Vitacura, Santiago, Chile
    Lung Cancer 42:S57-64. 2003
    ..We discuss here the available worldwide information on this subject. There is an urgent need for new trials in this topic...
  23. ncbi Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
    Rodrigo Arriagada
    Instituto de Radiomedicina, Santiago, Chile
    N Engl J Med 350:351-60. 2004
    ..Seven patients (0.8 percent) died of chemotherapy-induced toxic effects. CONCLUSIONS: Cisplatin-based adjuvant chemotherapy improves survival among patients with completely resected non-small-cell lung cancer...
  24. ncbi Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer?
    Monique G Le
    Institut Gustave Roussy IGR, Villejuif, France
    Breast 15:355-62. 2006
    ..The study was performed in two centers: one French including 49 IBC patients and 140 non-IBC and another Tunisian including 97 IBC and 139 non-IBC. Unconditional logistic regression was used for the analyses...
  25. ncbi Early breast cancer: adjuvant chemotherapy or radiotherapy, or both?
    Rodrigo Arriagada
    Acta Oncol 45:514-6. 2006
  26. ncbi Effect of radiation dose on local control in breast cancer
    Rodrigo Arriagada
    Radiother Oncol 86:285-6; author reply 286. 2008
  27. ncbi Enhanced local control by radiation boost in breast cancer: back side of the coin?
    Céline Bourgier
    J Clin Oncol 25:5841-3; author reply 5844-5. 2007
  28. ncbi Hypofractionation in radiotherapy for breast cancer
    Harry Bartelink
    Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands
    Lancet 371:1050-2. 2008
  29. ncbi Radiotherapy for breast cancer
    Rodrigo Arriagada
    N Engl J Med 346:862-4. 2002